CasaricoA., CalcagnoL., PasquiniP., GavazziL.: Chemioprofilassi intravescicale con CDDP del carcinoma uroteliale della vescica: risultati a distanza su 73 pazienti. Atti SIU, 60° Congr. Palermo. Acta Urol.1988 (in corso di stampa).
5.
DenisL.: Anaphylactic reactions to repeated intravesical instillation with cisplatin. Letter to the Editor. Lancet, 933; 1378 (1983).
6.
JacobiC. H., EngelmannU.: Studies on the absorption of intravesical chemotherapeutic agents under different conditions of instillation. In: Therapy and prophylaxis of superficial bladder carcinomas.Thieme Inc., New York1985.
7.
LermanR. I., HutterR. V. P., WhitmoreW. F.: Papilloma of the urinary bladder. Cancer, 25; 333 (1970).
8.
LoeningS., NarayanaA., YoderL.: Factors influencing the recurrence rate of bladder cancer. J. Urol., 123; 29 (1980).
9.
LutzeyerW., RubbenH., DahmH.: Prognostic parameters in superficial bladder cancer: an analysis of 315 cases. J. Urol., 127; 250 (1982).
10.
ScarpaR. M., OlianasR., MancaP., MigliariR., PorruD., CampusG., UsaiE.: La chemioprofilassi delle recidive di neoplasie vescicali superficiali: esperienza clinica sull'efficacia di Adriamicina, Mitomicina C e Cis-diamino-dicloro-platino. Atti SIU, 59° Congr., Milano 1986.
11.
SolowayM. S.: Intravesical and systemic chemotherapy in the management of superficial bladder cancer. Urol. Clin. N. Amer., 11; 623 (1984).
12.
UtzD. C., FarrowG. M.: Management of carcinoma in situ of the bladder: the case for surgical management. Urol. Clin. N. Amer., 7; 533 (1980).